Total Solutions Provider for the Biopharmaceutical Industry
As a leading partner of the biopharmaceutical industry, Sartorius Stedim Biotech helps its customers to develop their production processes and manufacture biotech medications and vaccines more efficiently. Sartorius Stedim Biotech is a globally operating company with subsidiaries in more than 25 countries and around 10,600 employees worldwide.
The parent company of the Sartorius Stedim Biotech Group is Sartorius Stedim Biotech S.A., headquartered in Aubagne, France and listed on the Euronext stock exchange in Paris. Approximately 72% of the share capital and around 83% of the voting rights of Sartorius Stedim Biotech S.A. are held by Sartorius AG.
Technologies for the Entire Added-Value Chain in Biopharmaceutical Production
Sartorius Stedim Biotech offers a broad portfolio of products that focuses on all major steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Our technologies cover, inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for their storage and transportation.
